Crossref
26-A-17373-ACC EFFECTIVENESS OF INCLISIRAN COMPARED TO ALIROCUMAB/EVOLOCUMAB IN PATIENTS WITH FAMILIAL OR SEVERE HYPERCHOLESTEROLEMIA
JACC · 2026-04 · 87 (13) · A217-A218
DOI: 10.1016/j.jacc.2026.02.538 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Krishna Patel und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patel, K., & Bajaj, A. (2026). 26-A-17373-ACC EFFECTIVENESS OF INCLISIRAN COMPARED TO ALIROCUMAB/EVOLOCUMAB IN PATIENTS WITH FAMILIAL OR SEVERE HYPERCHOLESTEROLEMIA. JACC, 87(13), A217-A218. https://doi.org/10.1016/j.jacc.2026.02.538
Vancouver
Patel K, Bajaj A. 26-A-17373-ACC EFFECTIVENESS OF INCLISIRAN COMPARED TO ALIROCUMAB/EVOLOCUMAB IN PATIENTS WITH FAMILIAL OR SEVERE HYPERCHOLESTEROLEMIA. JACC. 2026;87(13):A217-A218. doi:10.1016/j.jacc.2026.02.538
BibTeX
@article{Patel2026,
author = {Patel, Krishna and Bajaj, Archna},
title = {26-A-17373-ACC EFFECTIVENESS OF INCLISIRAN COMPARED TO ALIROCUMAB/EVOLOCUMAB IN PATIENTS WITH FAMILIAL OR SEVERE HYPERCHOLESTEROLEMIA},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A217--A218},
doi = {10.1016/j.jacc.2026.02.538}
}
EUVIMED